Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 25 Artikel )

07.05.2020 | editorial | Ausgabe 2/2020

Circumnavigating the challenges of COVID-19 in oncology

Thorsten Fuereder MD, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe, editors of memo

01.06.2020 | editorial | Ausgabe 2/2020

An update from the 2019 ESMO meeting

Andreas Pircher MD PhD

01.06.2020 | editorial | Ausgabe 2/2020

Diagnostic and therapeutic management of sarcoma patients

Andreas Seeber MD PhD

01.06.2020 | editorial | Ausgabe 2/2020

Epithelial ovarian cancer

Prof. Alexander Reinthaller M.D.

01.06.2020 | editorial | Ausgabe 2/2020

Hepatocellular carcinoma

Dr. Angela Djanani

18.03.2020 | short review | Ausgabe 2/2020 Open Access

ESMO 2019: breast cancer

Rupert Bartsch

20.03.2020 | short review | Ausgabe 2/2020 Open Access

ESMO 2019—personal non-small lung cancer highlights

Dr. Lena Horvath, PD Dr. Andreas Pircher

22.04.2020 | short review | Ausgabe 2/2020 Open Access

ESMO 2019—personal highlights in gastrointestinal cancer

A. Amann

15.04.2020 | short review | Ausgabe 2/2020

My personal highlights of ESMO 2019 regarding urogenital cancer

Dora Niedersüß-Beke

20.02.2020 | short review | Ausgabe 2/2020 Open Access

The role of pathology in sarcoma

Univ.-Prof. PD Dr. Bernadette Liegl-Atzwanger

09.03.2020 | short review | Ausgabe 2/2020 Open Access

The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities?

Reinhard Windhager MD, Gerhard M. Hobusch

15.01.2020 | short review | Ausgabe 2/2020

Radiotherapy in soft tissue sarcoma

Prof. Dr. Falk Röder

07.01.2020 | short review | Ausgabe 2/2020 Open Access

Perioperative treatment of soft-tissue sarcoma

Christian Rothermundt

15.04.2020 | short review | Ausgabe 2/2020

Metastatic sarcoma: tailored strategies for a heterogeneous disease

Massimiliano Grassi, Andrea Spagnoletti, Alberto Puccini MD

15.04.2020 | short review | Ausgabe 2/2020 Open Access

Therapy management in bone sarcoma

Associate Professor Martin Thaler MD, Ismail Khosravi MD

27.01.2020 | short review | Ausgabe 2/2020 Open Access

Screening for ovarian cancer: is there still hope?

PD Dr. Stefanie Aust PhD, Assoc. Prof. PD Dr. Veronika Seebacher-Shariat

15.04.2020 | short review | Ausgabe 2/2020 Open Access

Ovarian cancer surgery

Game-changing innovations
Richard Schwameis, Valentina Paspalj, Marlene Kranawetter, Assoc. Prof. PD Dr. Stephan Polterauer

13.03.2020 | review | Ausgabe 2/2020 Open Access

PARP inhibitors in the treatment of ovarian cancer

Alain G. Zeimet, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth

17.02.2020 | short review | Ausgabe 2/2020 Open Access

Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment

Thomas Bartl MD, Valentina Paspalj MD, Assoc.-Prof. PD Stephan Polterauer MD, Assoc.-Prof. PD Christoph Grimm MD

15.04.2020 | short review | Ausgabe 2/2020 Open Access

Thermal ablation—an option in curative treatment of HCC

Daniel Putzer, Peter Schullian, Gernot Eberle, Reto Josef Bale

20.03.2020 | short review | Ausgabe 2/2020 Open Access

Systemic therapy in advanced-stage hepatocellular carcinoma

Prof. Dr. Ivo Graziadei

23.03.2020 | short review | Ausgabe 2/2020

Immunotherapy in hepatocellular carcinoma

OÄ Dr. Stephanie Hametner-Schreil

15.04.2020 | review | Ausgabe 2/2020 Open Access

The intestinal microbiota and hepatocellular carcinoma

Maria Effenberger, Herbert Tilg M.D.

25.02.2020 | original report | Ausgabe 2/2020 Open Access

PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia

An observational, nonintervention study of real-life practice
Georgi Mihaylov, Barbara Skopec, Zuzana Sninska, Nikolai Tzvetkov, Olga Cerna, Vladlen Ivanushkin, Daniela Niepel, Katja Björklöf, Peter Černelč

03.03.2020 | original report | Ausgabe 2/2020

Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation

Layla M. Saleh MD, PhD, Reem Algamal, Hanaa Abd Elmasseh, Emily Barber, Hasan Abdel-ghaffar

Aktuelle Ausgaben